■ CD314 モノクローナル抗体(品番:65188-1-Ig)

図1. CD314抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1), and 0.5 ug Anti-Human CD314 (65188-1-Ig, Clone: 1D11) and FITC Anti-Mouse IgG1 Antibody. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1), and 0.5 ug Mouse IgG1 Isotype Control and FITC Anti-Mouse IgG1 Antibody. Cells were not fixed.
■ CD314 モノクローナル抗体(品番:FITC-65188)

図1. CD314抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1) and 4 ul FITC Anti-Human CD314 (FITC-65188, Clone: 1D11). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1) and FITC-Mouse IgG1 isotype control. Cells were not fixed.
■ CD314 モノクローナル抗体(品番:PE-65188)

図1. CD314抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1) and 10 ul PE Anti-Human CD314 (PE-65188, Clone: 1D11). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD8 (APC-65146, Clone: SK1) and PE-Mouse IgG1 isotype control. Cells were not fixed.
■ CD314 モノクローナル抗体(品番:APC-65188)

図1. CD314抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with PE Anti-Human CD8 (PE-65146,?Clone:SK1) and 10.00 ul/test APC Anti-Human CD314 (APC-65188, Clone:1D11). Samples were not fixed.
図2. アイソタイプコントロール抗体とCD8抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with PE Anti-Human CD8 (PE-65146,?Clone:SK1) and APC mouse IgG1 isotype control antibody. Samples were not fixed.